Sousa, N., Geiß, C., Bindila, L., Lieberwirth, I., Kim, E., & Régnier-Vigouroux, A. (2023). Targeting sphingolipid metabolism with the sphingosine kinase inhibitor SKI-II overcomes hypoxia-induced chemotherapy resistance in glioblastoma cells: effects on cell death, self-renewal, and invasion. BMC Cancer, 23: 762. doi:10.1186/s12885-023-11271-w.